vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and Limbach Holdings, Inc. (LMB). Click either name above to swap in a different company.
Limbach Holdings, Inc. is the larger business by last-quarter revenue ($186.9M vs $168.4M, roughly 1.1× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 30.1%). Over the past eight quarters, Limbach Holdings, Inc.'s revenue compounded faster (25.3% CAGR vs 10.6%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Limbach Flugmotoren is a Chinese-owned company based in Germany that produces aircraft engines.
ESPR vs LMB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $168.4M | $186.9M |
| Net Profit | — | $12.3M |
| Gross Margin | — | 25.7% |
| Operating Margin | 50.6% | 9.4% |
| Net Margin | — | 6.6% |
| Revenue YoY | 143.7% | 30.1% |
| Net Profit YoY | — | 25.0% |
| EPS (diluted) | $0.32 | $1.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $186.9M | ||
| Q3 25 | $87.3M | $184.6M | ||
| Q2 25 | $82.4M | $142.2M | ||
| Q1 25 | $65.0M | $133.1M | ||
| Q4 24 | $69.1M | $143.7M | ||
| Q3 24 | $51.6M | $133.9M | ||
| Q2 24 | $73.8M | $122.2M | ||
| Q1 24 | $137.7M | $119.0M |
| Q4 25 | — | $12.3M | ||
| Q3 25 | $-31.3M | $8.8M | ||
| Q2 25 | $-12.7M | $7.8M | ||
| Q1 25 | $-40.5M | $10.2M | ||
| Q4 24 | — | $9.8M | ||
| Q3 24 | $-29.5M | $7.5M | ||
| Q2 24 | $-61.9M | $6.0M | ||
| Q1 24 | $61.0M | $7.6M |
| Q4 25 | — | 25.7% | ||
| Q3 25 | — | 24.2% | ||
| Q2 25 | — | 28.0% | ||
| Q1 25 | — | 27.6% | ||
| Q4 24 | — | 30.3% | ||
| Q3 24 | — | 27.0% | ||
| Q2 24 | — | 27.4% | ||
| Q1 24 | — | 26.1% |
| Q4 25 | 50.6% | 9.4% | ||
| Q3 25 | -11.4% | 7.2% | ||
| Q2 25 | 8.6% | 7.5% | ||
| Q1 25 | -34.0% | 5.9% | ||
| Q4 24 | -6.4% | 9.1% | ||
| Q3 24 | -31.0% | 8.1% | ||
| Q2 24 | 3.5% | 6.7% | ||
| Q1 24 | 52.5% | 5.5% |
| Q4 25 | — | 6.6% | ||
| Q3 25 | -35.9% | 4.8% | ||
| Q2 25 | -15.4% | 5.5% | ||
| Q1 25 | -62.2% | 7.7% | ||
| Q4 24 | — | 6.9% | ||
| Q3 24 | -57.2% | 5.6% | ||
| Q2 24 | -83.9% | 4.9% | ||
| Q1 24 | 44.3% | 6.4% |
| Q4 25 | $0.32 | $1.01 | ||
| Q3 25 | $-0.16 | $0.73 | ||
| Q2 25 | $-0.06 | $0.64 | ||
| Q1 25 | $-0.21 | $0.85 | ||
| Q4 24 | $-0.14 | $0.81 | ||
| Q3 24 | $-0.15 | $0.62 | ||
| Q2 24 | $-0.33 | $0.50 | ||
| Q1 24 | $0.34 | $0.64 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $11.3M |
| Total DebtLower is stronger | — | $30.5M |
| Stockholders' EquityBook value | $-302.0M | $195.7M |
| Total Assets | $465.9M | $381.1M |
| Debt / EquityLower = less leverage | — | 0.16× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $11.3M | ||
| Q3 25 | $92.4M | $9.8M | ||
| Q2 25 | $86.1M | $38.9M | ||
| Q1 25 | $114.6M | $38.1M | ||
| Q4 24 | $144.8M | $44.9M | ||
| Q3 24 | $144.7M | $51.2M | ||
| Q2 24 | $189.3M | $59.5M | ||
| Q1 24 | $226.6M | $48.2M |
| Q4 25 | — | $30.5M | ||
| Q3 25 | — | $56.3M | ||
| Q2 25 | — | $28.4M | ||
| Q1 25 | — | $23.7M | ||
| Q4 24 | — | $23.6M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $19.7M | ||
| Q1 24 | — | $19.4M |
| Q4 25 | $-302.0M | $195.7M | ||
| Q3 25 | $-451.4M | $181.6M | ||
| Q2 25 | $-433.5M | $170.5M | ||
| Q1 25 | $-426.2M | $161.1M | ||
| Q4 24 | $-388.7M | $153.5M | ||
| Q3 24 | $-370.2M | $142.2M | ||
| Q2 24 | $-344.2M | $133.0M | ||
| Q1 24 | $-294.3M | $125.5M |
| Q4 25 | $465.9M | $381.1M | ||
| Q3 25 | $364.0M | $409.1M | ||
| Q2 25 | $347.1M | $343.0M | ||
| Q1 25 | $324.0M | $336.4M | ||
| Q4 24 | $343.8M | $352.1M | ||
| Q3 24 | $314.1M | $324.4M | ||
| Q2 24 | $352.3M | $303.9M | ||
| Q1 24 | $373.1M | $289.2M |
| Q4 25 | — | 0.16× | ||
| Q3 25 | — | 0.31× | ||
| Q2 25 | — | 0.17× | ||
| Q1 25 | — | 0.15× | ||
| Q4 24 | — | 0.15× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $28.1M |
| Free Cash FlowOCF − Capex | — | $27.9M |
| FCF MarginFCF / Revenue | — | 14.9% |
| Capex IntensityCapex / Revenue | 0.0% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 2.29× |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $28.1M | ||
| Q3 25 | $-4.3M | $13.3M | ||
| Q2 25 | $-31.4M | $2.0M | ||
| Q1 25 | $-22.6M | $2.2M | ||
| Q4 24 | $-35.0M | $19.3M | ||
| Q3 24 | $-35.3M | $4.9M | ||
| Q2 24 | $-7.2M | $16.5M | ||
| Q1 24 | $53.8M | $-3.9M |
| Q4 25 | — | $27.9M | ||
| Q3 25 | — | $12.8M | ||
| Q2 25 | — | $1.2M | ||
| Q1 25 | — | $11.0K | ||
| Q4 24 | — | $18.0M | ||
| Q3 24 | $-35.5M | $4.6M | ||
| Q2 24 | $-7.3M | $13.2M | ||
| Q1 24 | $53.8M | $-6.5M |
| Q4 25 | — | 14.9% | ||
| Q3 25 | — | 7.0% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 12.5% | ||
| Q3 24 | -68.7% | 3.4% | ||
| Q2 24 | -9.9% | 10.8% | ||
| Q1 24 | 39.0% | -5.5% |
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.0% | 0.3% | ||
| Q2 25 | 0.0% | 0.6% | ||
| Q1 25 | 0.0% | 1.7% | ||
| Q4 24 | 0.0% | 0.9% | ||
| Q3 24 | 0.3% | 0.3% | ||
| Q2 24 | 0.1% | 2.7% | ||
| Q1 24 | 0.1% | 2.1% |
| Q4 25 | — | 2.29× | ||
| Q3 25 | — | 1.52× | ||
| Q2 25 | — | 0.26× | ||
| Q1 25 | — | 0.22× | ||
| Q4 24 | — | 1.96× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 2.77× | ||
| Q1 24 | 0.88× | -0.52× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
LMB
| Owner Direct Relationships Segment | $145.0M | 78% |
| General Contractor Construction Manager Relationships Segment | $41.9M | 22% |